by ARTILLERY | Oct 8, 2024 | News
Giving appropriate patients the option to self-administer¹ACTEMRA® (tocilizumab) is available in different routes of administration to meet patients’ needs. Some patients may prefer the ACTEMRA ACTPen® autoinjector, which is self-administered once a week or once every...
by ARTILLERY | Sep 9, 2024 | News
Payer coverage information for select RA patients in California 79% of patients in California have coverage for ACTEMRA® (tocilizumab) IV with no step edits.1 In a changing treatment landscape, Genentech remains committed to ensuring patients with rheumatoid arthritis...
by ARTILLERY | May 1, 2024 | News
In the battle against chronic diseases, patients face an unexpected adversary: ‘copay accumulators’ jeopardizing access to life-saving medications, forcing impossible choices between health and sustenance. CRA President, Samy Metyas, MD shares his opinion...
by ARTILLERY | Feb 16, 2024 | News
Pfizer’s Myositis Research Do you have patients with Dermatomyositis or Polymyositis who may be eligible to participate in an ongoing Phase 3 clinical research study? • This study is currently recruiting in 9 states in the USA and will add additional sites...
by Shanna Castro | Jan 10, 2024 | News
Apart from the high transmission rate globally, the coronavirus disease 2019 (COVID-19) pandemic has seen a record number of clinical studies registered on ClinicalTrials.gov.From January 2020 to May 2020, there have been 17,998 published articles and 4385 preprints...
by Shanna Castro | Jan 10, 2024 | News
Many questions remain about how flu season might affect the pandemic, and vice versa. For example, would coinfection with influenza worsen the course of COVID-19? Experts also aren’t certain whether influenza vaccination could help protect against COVID-19 or whether...
